PharmAlert.net

PharmAlert Xagena

XagenaNewsletter
Xagena Mappa
Medical Meeting
Onco News

FDA against the use of homeopathic teething tablets and gels


The FDA ( Food and Drug Administration ) has warned consumers that homeopathic teething tablets and gels may pose a risk to infants and children.
The FDA has recommended that consumers stop using these products and dispose of any in their possession.

Homeopathic teething tablets and gels are distributed by CVS, Hyland’s, and possibly others, and are sold in retail stores and online.

Consumers should seek medical care immediately if their child experiences seizures, difficulty breathing, lethargy, excessive sleepiness, muscle weakness, skin flushing, constipation, difficulty urinating, or agitation after using homeopathic teething tablets or gels.

Teething can be managed without prescription or over-the-counter remedies.

The FDA is analyzing adverse events reported to the Agency regarding homeopathic teething tablets and gels, including seizures in infants and children who were given these products, since a 2010 safety alert about homeopathic teething tablets.
The FDA is currently investigating this issue, including testing product samples.

Homeopathic teething tablets and gels have not been evaluated or approved by the FDA for safety or efficacy.
The Agency is also not aware of any proven health benefit of the products, which are labeled to relieve teething symptoms in children. ( Xagena )

Source: FDA, 2016

XagenaMedicine_2016



Indietro